Ainos, Inc. (AIMD)

Market Cap	10.75M +31.1%
Revenue (ttm)	124,157 +499.0%
Net Income	-14.77M
EPS	-3.46
Shares Out	7.27M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,040
Open	1.470
Previous Close	1.490
Day's Range	1.420 - 1.490
52-Week Range	1.260 - 4.500
Beta	2.32
Analysts	n/a
Price Target	n/a
Earnings Date	May 11, 2026

About AIMD

Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women’s health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. The company was formerly known as Amarillo ...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1984
• Employees: 44
• Stock Exchange: NASDAQ
• Ticker Symbol: AIMD
• Website: https://www.ainos.com

Financial Performance

In 2025, Ainos's revenue was $124,157, an increase of 498.95% compared to the previous year's $20,729. Losses were -$14.77 million, -0.62% less than in 2024.